Skip to main content

ADVERTISEMENT

cost-effectiveness research

Research Reports
10/16/2017
Chadi Nabhan, MD, MBA, FACP
Yolaine Jeune-Smith, PhD
Peter Klinefelter, BA
Jennifer Fillman, MBA
Bruce A. Feinberg, DO
Abstract: The Oncologic Drugs Advisory Committee recently voted 10-0 recommending to the Food and Drug Administration (FDA) the approval of the first chimeric antigen receptor T (CAR-T) therapy. We sought to better...
Abstract: The Oncologic Drugs Advisory Committee recently voted 10-0 recommending to the Food and Drug Administration (FDA) the approval of the first chimeric antigen receptor T (CAR-T) therapy. We sought to better...
...
10/16/2017
Journal of Clinical Pathways
Research in Review
07/25/2017
JCP Editors
Adherence to distress screening protocols could lead to 18% fewer ER visits and 19% fewer hospitalizations, according to a recent study published in Journal of the National Comprehensive Cancer Network (July...
Adherence to distress screening protocols could lead to 18% fewer ER visits and 19% fewer hospitalizations, according to a recent study published in Journal of the National Comprehensive Cancer Network (July...
...
07/25/2017
Journal of Clinical Pathways
Research in Review
07/18/2017
JCP Editors
A biomarker screening pathway for monogenic diabetes is an effective and easy approach to systematically screening young-onset patients, according to results of a population-based assessment published in Diabetes...
A biomarker screening pathway for monogenic diabetes is an effective and easy approach to systematically screening young-onset patients, according to results of a population-based assessment published in Diabetes...
A...
07/18/2017
Journal of Clinical Pathways
Research in Review
06/29/2017
JCP Editors
Patients with chronic myeloid leukemia (CML) who receive half the standard dose of tyrosine kinase inhibitor (TKI) therapy are likely to eliminate most adverse events, drastically reduce costs, and improve...
Patients with chronic myeloid leukemia (CML) who receive half the standard dose of tyrosine kinase inhibitor (TKI) therapy are likely to eliminate most adverse events, drastically reduce costs, and improve...
...
06/29/2017
Journal of Clinical Pathways
Research in Review
06/23/2017
JCP Editors
Continuous subcutaneous insulin infusion (CSII) is associated with increased hypoglycemia encounters and health care expenditures, according to research published in the American Journal of Managed Care (June 21,...
Continuous subcutaneous insulin infusion (CSII) is associated with increased hypoglycemia encounters and health care expenditures, according to research published in the American Journal of Managed Care (June 21,...
...
06/23/2017
Journal of Clinical Pathways
Research in Review
06/20/2017
JCP Editors
A lay navigation program for older survivors of cancer can reduce hospitalizations, emergency department (ED) visits, and intensive care unit admissions, resulting in lower health care costs. ----- Related...
A lay navigation program for older survivors of cancer can reduce hospitalizations, emergency department (ED) visits, and intensive care unit admissions, resulting in lower health care costs. ----- Related...
A lay...
06/20/2017
Journal of Clinical Pathways
06/13/2017
EXECUTIVE SUMMARY Gastric cancer is the fifth most diagnosed cancer worldwide and the third leading cause of cancer deaths. In the United States and other countries with low rates of gastric cancer, the population...
EXECUTIVE SUMMARY Gastric cancer is the fifth most diagnosed cancer worldwide and the third leading cause of cancer deaths. In the United States and other countries with low rates of gastric cancer, the population...
...
06/13/2017
Journal of Clinical Pathways
Research in Review
06/13/2017
JCP Editors
A cost-effectiveness analysis showed that patients with rheumatoid arthritis (RA) who switch from a disease-modifying antirheumatic drug (DMARD) to a biologic drug are likely to increase costs of care while receiving...
A cost-effectiveness analysis showed that patients with rheumatoid arthritis (RA) who switch from a disease-modifying antirheumatic drug (DMARD) to a biologic drug are likely to increase costs of care while receiving...
A...
06/13/2017
Journal of Clinical Pathways
Research in Review
05/31/2017
JCP Editors
Women who have been treated for early-stage breast cancer and receive surveillance testing are at risk of adverse events and increased financial burden, according to research that will be presented at the 2017 ASCO...
Women who have been treated for early-stage breast cancer and receive surveillance testing are at risk of adverse events and increased financial burden, according to research that will be presented at the 2017 ASCO...
Women...
05/31/2017
Journal of Clinical Pathways
Department
03/15/2017
JCP Editors
The cost of colon cancer care rose significantly during the period from 2003 to 2013, despite decreases in overall hospitalizations and lengths of stay. ----- Related Content Adjuvant Chemotherapy Improves Colon...
The cost of colon cancer care rose significantly during the period from 2003 to 2013, despite decreases in overall hospitalizations and lengths of stay. ----- Related Content Adjuvant Chemotherapy Improves Colon...
The...
03/15/2017
Journal of Clinical Pathways